Home › Funds › Cormorant Asset Management, LP › ACRS
Cormorant Asset Management, LP position in ACRS
ACLARIS THERAPEUTICS INC · Health Care
Cormorant Asset Management, LP reported holding 1,750,000 shares of ACRS (ACLARIS THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$9.2M, representing 0.66% of its reported portfolio and ranking #36 among its reported holdings. Cormorant Asset Management, LP first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Cormorant Asset Management, LP's ACRS position evolved
Cormorant Asset Management, LP first disclosed a stake in ACRS in Q3 2026 at 1,750,000 shares (US$9.2M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 1.75M | $9.21M | New |
About ACRS and 13F data
ACRS (ACLARIS THERAPEUTICS INC) is a Health Care company. 46 other funds we track also report a position in ACRS — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$66.9M), BML Capital Management, LLC (US$57.6M), Deep Track Capital, LP (US$49.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ACRS
- RA CAPITAL MANAGEMENT, L.P. 12.72M sh · $66.92M · Q3 2026
- BML Capital Management, LLC 10.96M sh · $57.62M · Q3 2026
- Deep Track Capital, LP 9.35M sh · $49.15M · Q3 2026
- Frazier Life Sciences Management, L.P. 8.73M sh · $45.92M · Q3 2026
- Vivo Capital, LLC 6.69M sh · $35.21M · Q3 2026
- MPM BioImpact LLC 5.18M sh · $27.24M · Q3 2026
- Decheng Capital LLC 4.04M sh · $21.26M · Q3 2026
- Rock Springs Capital Management LP 3.79M sh · $19.94M · Q3 2026
- Jones Hill Capital LP 2.50M sh · $13.17M · Q3 2026
- STEMPOINT CAPITAL LP 2.05M sh · $10.79M · Q3 2026
- Kalehua Capital Management LLC 1.83M sh · $9.64M · Q3 2026
- Squadron Capital Management LLC 1.20M sh · $6.31M · Q3 2026
More on Cormorant Asset Management, LP
FAQ
How long has Cormorant Asset Management, LP held ACRS?
Cormorant Asset Management, LP has disclosed ACRS holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Cormorant Asset Management, LP's current position in ACRS?
As of Q3 2026, Cormorant Asset Management, LP holds 1.75M shares of ACRS (ACLARIS THERAPEUTICS INC), valued at $9.21M, representing 0.66% of its reported portfolio and ranking #36.
Has Cormorant Asset Management, LP been buying or selling ACRS?
In the latest 13F filing (Q3 2026), Cormorant Asset Management, LP newly opened its position in ACRS.
Which other funds hold ACRS?
Other major institutional holders of ACRS include RA CAPITAL MANAGEMENT, L.P., BML Capital Management, LLC, Deep Track Capital, LP, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.